-
hcup-us.ahrq.gov/reports/methods/2013_01.pdf
January 01, 2013 - maternal and child health programs, state-county run mental health and substance
abuse programs, black lung … maternal and child health programs,
state-county run mental health and substance abuse programs, black lung
-
hcup-us.ahrq.gov/reports/methods/2019-02.pdf
January 01, 2019 - maternal and child health programs, state-county run mental health and substance
abuse programs, black lung … maternal and child health programs,
state-county run mental health and substance abuse programs, black lung
-
hcup-us.ahrq.gov/reports/methods/2016-04.pdf
January 01, 2016 - maternal and child health programs, state-county run mental health and substance
abuse programs, black lung … maternal and child health programs,
state-county run mental health and substance abuse programs, black lung
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/references/meta/meta03.html
December 01, 2012 - Smoking cessation with four nicotine replacement regimes in a lung clinic.
-
www.ahrq.gov/research/findings/nhqrdr/chartbooks/healthyliving/lifestyle.html
June 01, 2018 - attributable to smoking and exposure to secondhand smoke. 3
Smoking causes more than 87% of deaths from lung
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-1996
January 01, 1996 - A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers
-
psnet.ahrq.gov/node/846171/psn-pdf
July 26, 2022 - Heart Lung. 2019;48:226-235. [Free full text]
6. Fan E, Tan S, Ang S.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - FDA recommends that
Afrezza should not be used in patients with chronic lung disease, such as asthma … inhalation, the
patient’s breath powers the inhaler to aerosolize the powder so that it reaches the lungs … Trials lasted
up to 2 years and excluded patients with chronic lung disease. … treated with Afrezza had a
40 mL (95% CI, -80 to -1) greater decline from baseline in a measure of lung … risk of acute
bronchospasm.87 FDA advises that Afrezza should not be used in patients with chronic lung
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dxsafety-facilitators-guide.pdf
February 04, 2022 - managed for a recurrent
right-sided pleural effusion (excess fluid in the space that surrounds the lungs … being considered for a kidney transplant when his dialysis began to fail, an
eventual diagnosis of lung … findings
My working diagnosis or
suspected etiology is COPD
My differential diagnosis includes
Lung … Consultant Diagnostic Assessment/Feedback
Chest CT scan revealed lung damage likely caused by emphysema … by congestive
heart failure, pulmonary embolism, spontaneous pneumothorax,
undiagnosed obstructive lung
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - National Heart Lung and Blood Institute
(NHLBI), Obesity Education Initiative, Expert
Panel on the … and Human Services,
Public Health Service, National Institutes of
Health (NIH), National Heart Lung … National Heart Lung and Blood Institute
(NHLBI). Key recommendations. [internet]. … Bethesda (MD): National Heart Lung and Blood
Institute (NHLBI), National Institutes of Health
(NIH
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2004 - , August 31, 2006
APRDRG Frequency
Percent
of
Total
1: LIVER TRANSPLANT 142 0.02
2: HEART &/OR LUNG … 2.76
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13219 1.65
141: ASTHMA 6047 0.76
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2246 0.28
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 350 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC 12 … RES11: Influenza 424 0.05
RES12: Mycoplasma pneumoniae Infection 104 0.01
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2002 - .: Missing 35975 4.58
1: LIVER TRANSPLANT 101 0.01
2: HEART &/OR LUNG TRANSPLANT 60 0.01
3: BONE MARROW … 2.78
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12735 1.62
141: ASTHMA 5929 0.75
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2118 0.27
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 305 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC 11 0.00
4952: LUNG TRANSPLANT W MCC 13 0.00 … : Influenza 446 0.06
RES12: Mycoplasma pneumoniae Infection 109 0.01
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2002 - .: Missing 35974 4.58
1: LIVER TRANSPLANT 102 0.01
2: HEART &/OR LUNG TRANSPLANT 67 0.01
3: BONE MARROW … 2.75
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13026 1.66
141: ASTHMA 6220 0.79
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2114 0.27
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 311 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC < … RES11: Influenza 449 0.06
RES12: Mycoplasma pneumoniae Infection 96 0.01
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2004 - , August 31, 2006
APRDRG Frequency
Percent
of
Total
1: LIVER TRANSPLANT 137 0.02
2: HEART &/OR LUNG … 2.75
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13243 1.65
141: ASTHMA 6110 0.76
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2229 0.28
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 353 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC < … RES11: Influenza 437 0.05
RES12: Mycoplasma pneumoniae Infection 121 0.02
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2003_SummaryStats_SEVERITY.PDF
January 01, 2003 - December 14, 2005
APRDRG Frequency
Percent
of
Total
1: LIVER TRANSPLANT 335 0.01
2: HEART &/OR LUNG … 3.14
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 839 0.03
141: ASTHMA 100665 3.37
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 1906 0.06
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 132 0.00
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC 34 … Influenza 16207 0.54
RES12: Mycoplasma pneumoniae Infection 1876 0.06
RES13: Neoplasm, Malignant: Lungs
-
psnet.ahrq.gov/web-mm/amphotericin-toxicity
April 01, 2014 - Amphotericin Toxicity
Citation Text:
Nagel J, Nguyen E. Amphotericin Toxicity. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2015.
Copy Citation
Format:
Google Scholar BibTeX EndNote X3 XML EndNote 7 XML Endnote tagged…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hWPZYvUZJXUQghbFtSDC42
August 01, 2011 - In comparison, in 2009
there were an estimated 219 440 new cases of lung cancer
and 159 390 deaths, 146
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs022911-chaudhry-final-report-2017.pdf
January 01, 2017 - surveillance of colon polyps that requires reading of text pathology
report and colonoscopy report; lung
-
psnet.ahrq.gov/web-mm/agitated-delirium-contributes-missed-testing-and-delayed-diagnosis-gastric-perforation
June 28, 2023 - Heart Lung . 2019;48:226-235. [ Free full text ]
Fan E, Tan S, Ang S.
-
psnet.ahrq.gov/web-mm/case-mistaken-capacity-why-thorough-psychosocial-history-can-improve-care
July 08, 2022 - outpatient or home-based palliative care, patients with cancer, advanced heart failure, or advanced chronic lung